Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a shared framework make disability care more coordinated?

NCT ID NCT07813806

Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

Researchers are testing whether an interdisciplinary case management approach built on the International Classification of Functioning, Disability and Health (ICF) improves rehabilitation for adults with mild to moderate intellectual disabilities. The trial enrolls 120 adults from community rehabilitation services and randomly assigns them to either ICF-based case management or conventional care management. The ICF group receives coordinated assessments, shared goal-setting, care planning, and regular team reviews. The study measures changes in functioning, daily participation, quality of life, life satisfaction, and team effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ICF-based interdisciplinary case management using the Rehab-Cycle process
What this could lead to
If it works, this approach could give community rehabilitation teams a more coordinated, personalized way to plan care for adults with intellectual disabilities.
What could go wrong
This is a single behavioral study of 120 people, so results may not apply to other settings or disability groups. Case management depends on staff training and coordination, which can vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. between the age of 18 and 60 years old, 2. intellectual disability with mild grade (IQ 50-69) or moderate grade (IQ 35-49) as confirmed by medical doctors, 3. ability to communicate verbally in Cantonese or English. Exclusion Criteria: 1. acute and unstable medical conditions (such as seizures), 2. Current or recent diagnosis of severe psychiatric disorders (e.g., active psychosis, major depressive episode within the past 12 months, or other conditions that significantly impair participation) Their caregivers will provide proxy consent if the participants with intellectual disability were unable to give the informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Developmental disability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

developmental disability intellectual disability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Developmental disability Intellectual disability, mild to moderate

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Hong Kong Polytechnic University

    RECRUITING

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.